John Dean – Parkinson’s Rehab Teams: Moving Beyond a One-Size-Fits-All Approach

Description

Handouts

Outline

REVIEW OF PARKINSON’S DISEASE AND RELATED DISORDERS

• History of Parkinson’s

PARKINSON’S MEDICATIONS

• Basic methods of action for primary PD medication
• Common ancillary medications for:
  • Psychological symptoms
  • Orthostatic hypotension
  • Incontinence
  • Daytime fatigue/sleepiness
  • Cognitive changes
• Timing of PT/OT/ST interventions in conjunction with meds

{CASE STUDY} RECENTLY DIAGNOSED MALE WITH YOUNG ONSET PD

ADVANCED THERAPIES FOR PARKINSON’S

• Deep brain stimulator surgery (side effects and issues)
• Enteral suspension of carbidopa/levodopa
• Ablative surgeries
• On the horizon – subcutaneous continuous release of apomorphine and carbidopa/levodopa, A2A receptor antagonists and other targets

{CASE STUDY} FEMALE WITH MID-STAGE PD, S/P DBS SURGERY

OVERVIEW AND HISTORY OF REHAB TEAM APPROACHES TO TREATMENT

• Center of Excellence Model
• Interdisciplinary and transdisciplinary team models around the world

KEY ASPECTS OF PARKINSON’S TEAM DEVELOPMENT

• Key training and competencies
• Roles of key members including discipline-specific competencies
  • Gait and balance deficits
  • Functional transfers
  • ADLs
  • Communication and swallowing deficiencies

ASSESSMENTS AND DOCUMENTATION

• Intake and evaluation
• Key metrics of clinical progress including minimum detectable-change

SPECIAL TOPICS

• Dual task treatment for PD with PT/OT/ST team
  • Key concepts with research underpinning
  • Techniques for team approaches
    • Sequencing activities
    • Safety awareness
    • Memory deficits
• Marketing a team-based Parkinson’s program
  • Including sample presentations for consumer populations as well as medical presentations
  • Sample press release
• Differential diagnosis of atypical Parkinson’s disorders
  • Specific clinical features
    • Progressive supranuclear palsy
    • Corticobasal ganglionic degeneration
    • Multiple system atrophy

{CASE STUDY} FEMALE W/ 4-YEAR HISTORY OF UNSPECIFIED PARKINSONISMS

Faculty

John Dean, MA, CCC-SLP Related seminars and products: 4

---

John Dean, MA, CCC-SLP, has been specializing in the treatment of Parkinson’s and related disorders since 2007. In addition to clinical work, he has been involved in an array of Parkinson’s related projects ranging from the development of interdisciplinary Parkinson’s rehab networks for a large healthcare company, founding startups that build technologies for people living with Parkinson’s and even a stint as a member of the senior leadership at the Davis Phinney Foundation.

He resides in Lisbon, collaborating with Josefa Domingos to develop exercise activities that combine movement, voice, and cognition, as well as launching a startup that creates technologies to help scale up dual-task training for patients around the world.

Speaker Disclosures:

Financial: John Dean maintains a private practice. He is director at Davis Phinney Foundation. Mr. Dean receives a speaking honorarium from PESI, Inc.

Non-financial: John Dean is a member of the American Speech-Language-Hearing Association; and the International Parkinson and Movement Disorder Society (MDS).